Literature DB >> 22595409

Sudden cardiac death in patients with human immunodeficiency virus infection.

Zian H Tseng1, Eric A Secemsky, David Dowdy, Eric Vittinghoff, Brian Moyers, Joseph K Wong, Diane V Havlir, Priscilla Y Hsue.   

Abstract

OBJECTIVES: The aim of this study was to determine the incidence and clinical characteristics of sudden cardiac death (SCD) in patients with human immunodeficiency virus (HIV) infection.
BACKGROUND: As the HIV-infected population ages, cardiovascular disease prevalence and mortality are increasing, but the incidence and features of SCD have not yet been described.
METHODS: The records of 2,860 consecutive patients in a public HIV clinic in San Francisco between April 2000 and August 2009 were examined. Identification of deaths, causes of death, and clinical characteristics were obtained by search of the National Death Index and/or clinic records. SCDs were determined using published retrospective criteria: 1) the International Classification of Diseases-10th Revision, code for all cardiac causes of death; and (2) circumstances of death meeting World Health Organization criteria.
RESULTS: Of 230 deaths over a median of 3.7 years of follow-up, 30 (13%) met SCD criteria, 131 (57%) were due to acquired immune deficiency syndrome (AIDS), 25 (11%) were due to other (natural) diseases, and 44 (19%) were due to overdoses, suicides, or unknown causes. SCDs accounted for 86% of all cardiac deaths (30 of 35). The mean SCD rate was 2.6 per 1,000 person-years (95% confidence interval: 1.8 to 3.8), 4.5-fold higher than expected. SCDs occurred in older patients than did AIDS deaths (mean 49.0 vs. 44.9 years, p = 0.02). Compared with AIDS and natural deaths combined, SCDs had a higher prevalence of prior myocardial infarction (17% vs. 1%, p < 0.0005), cardiomyopathy (23% vs. 3%, p < 0.0005), heart failure (30% vs. 9%, p = 0.004), and arrhythmias (20% vs. 3%, p = 0.003).
CONCLUSIONS: SCDs account for most cardiac and many non-AIDS natural deaths in HIV-infected patients. Further investigation is needed to ascertain underlying mechanisms, which may include inflammation, antiretroviral therapy interruption, and concomitant medications.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22595409      PMCID: PMC3356565          DOI: 10.1016/j.jacc.2012.02.024

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  24 in total

Review 1.  Sudden cardiac death.

Authors:  D P Zipes; H J Wellens
Journal:  Circulation       Date:  1998-11-24       Impact factor: 29.690

2.  Sudden cardiac death in the United States, 1989 to 1998.

Authors:  Z J Zheng; J B Croft; W H Giles; G A Mensah
Journal:  Circulation       Date:  2001-10-30       Impact factor: 29.690

3.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

Review 4.  HIV-associated cardiomyopathy etiopathogenesis and clinical aspects.

Authors:  Giuseppe Barbaro
Journal:  Herz       Date:  2005-09       Impact factor: 1.443

5.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Authors: 
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

6.  Long QTc and torsades de pointes in human immunodeficiency virus disease.

Authors:  A G Kocheril; S A Bokhari; W P Batsford; A J Sinusas
Journal:  Pacing Clin Electrophysiol       Date:  1997-11       Impact factor: 1.976

7.  Predicting sudden death in the population: the Paris Prospective Study I.

Authors:  X Jouven; M Desnos; C Guerot; P Ducimetière
Journal:  Circulation       Date:  1999-04-20       Impact factor: 29.690

8.  QT interval prolongation predicts cardiovascular mortality in an apparently healthy population.

Authors:  E G Schouten; J M Dekker; P Meppelink; F J Kok; J P Vandenbroucke; J Pool
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

9.  Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community.

Authors:  Sumeet S Chugh; Jonathan Jui; Karen Gunson; Eric C Stecker; Benjamin T John; Barbara Thompson; Nasreen Ilias; Catherine Vickers; Vivek Dogra; Mohamud Daya; Jack Kron; Zhi-Jie Zheng; George Mensah; John McAnulty
Journal:  J Am Coll Cardiol       Date:  2004-09-15       Impact factor: 24.094

10.  CD4+ count-guided interruption of antiretroviral treatment.

Authors:  W M El-Sadr; J D Lundgren; J D Neaton; F Gordin; D Abrams; R C Arduino; A Babiker; W Burman; N Clumeck; C J Cohen; D Cohn; D Cooper; J Darbyshire; S Emery; G Fätkenheuer; B Gazzard; B Grund; J Hoy; K Klingman; M Losso; N Markowitz; J Neuhaus; A Phillips; C Rappoport
Journal:  N Engl J Med       Date:  2006-11-30       Impact factor: 91.245

View more
  118 in total

1.  Prolongation of the QTc interval in HIV-infected individuals compared to the general population.

Authors:  Nico Reinsch; Marina Arendt; Marie Henrike Geisel; Christina Schulze; Volker Holzendorf; Anna Warnke; Till Neumann; Norbert H Brockmeyer; Dirk Schadendorf; Lewin Eisele; Raimund Erbel; Susanne Moebus; Karl-Heinz Jöckel; Stefan Esser
Journal:  Infection       Date:  2017-08-03       Impact factor: 3.553

Review 2.  Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults.

Authors:  Robert C Kaplan; David B Hanna; Jorge R Kizer
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

3.  A case of human immunodeficiency virus-related heart failure resembling dilated cardiomyopathy but accompanied by high cardiac output.

Authors:  Noriaki Tabata; Megumi Yamamuro; Seigo Sugiyama; Michio Mizobe; Seiji Takashio; Kenichi Tsujita; Eiichiro Yamamoto; Tomoko Tanaka; Sunao Kojima; Koichi Kaikita; Shinji Tayama; Seiji Hokimoto; Chiharu Syudo; Toshikazu Miyakawa; Hiroaki Mitsuya; Hisao Ogawa
Journal:  J Cardiol Cases       Date:  2014-08-26

Review 4.  Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research.

Authors:  Joshua Remick; Vasiliki Georgiopoulou; Catherine Marti; Igho Ofotokun; Andreas Kalogeropoulos; William Lewis; Javed Butler
Journal:  Circulation       Date:  2014-04-29       Impact factor: 29.690

Review 5.  HIV and Cardiovascular Disease: Update on Clinical Events, Special Populations, and Novel Biomarkers.

Authors:  Kaku So-Armah; Matthew S Freiberg
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

6.  Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men.

Authors:  Markella V Zanni; Suhny Abbara; Janet Lo; Bryan Wai; David Hark; Eleni Marmarelis; Steven K Grinspoon
Journal:  AIDS       Date:  2013-05-15       Impact factor: 4.177

7.  Effect of left ventricular dysfunction and viral load on risk of sudden cardiac death in patients with human immunodeficiency virus.

Authors:  Brian S Moyers; Eric A Secemsky; Eric Vittinghoff; Joseph K Wong; Diane V Havlir; Priscilla Y Hsue; Zian H Tseng
Journal:  Am J Cardiol       Date:  2014-01-16       Impact factor: 2.778

8.  Heart rate variability and heart rate turbulence in HIV-infected patients receiving combination antiretroviral therapy.

Authors:  Wanwarang Wongcharoen; Kolakrit Khienprasit; Arintaya Phrommintikul; Apichard Sukonthasarn; Nipon Chattipakorn
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-06-09       Impact factor: 1.468

9.  Time to Recognize HIV Infection as a Major Cardiovascular Risk Factor.

Authors:  Priscilla Y Hsue; David D Waters
Journal:  Circulation       Date:  2018-09-11       Impact factor: 29.690

10.  Inflammation and Fibrosis in HIV: Getting to the Heart of the Matter.

Authors:  Priscilla Y Hsue; Ahmed Tawakol
Journal:  Circ Cardiovasc Imaging       Date:  2016-03       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.